SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yanwei Zhong, Jiyun Lv, Jin Li, Xiaoyan Xing, Hua Zhu, Heling Su, Li Chen, Xianzhi Zhou, Prevalence, virology and antiviral drugs susceptibility of hepatitis B virus rtN238H polymerase mutation from 1865 Chinese patients with chronic hepatitis B, Antiviral Research, 2012, 93, 1, 185

    CrossRef

  2. 2
    Li-Chun Wang, En-Qiang Chen, Xiao-Feng Zhu, Zhong-Hua Xiong, Li Liu, Lu Xu, Xue-Zhong Lei, Cong Liu, Hong Tang, Factors Predicting the Effi cacy of Adefovir Dipivoxil on Treatment-Naïve Chronic Hepatitis B Patients at 48 Weeks, Gut and Liver, 2011, 5, 4, 478

    CrossRef

  3. 3
    J. Inoue, Y. Ueno, Y. Wakui, H. Niitsuma, K. Fukushima, Y. Yamagiwa, M. Shiina, Y. Kondo, E. Kakazu, K. Tamai, N. Obara, T. Iwasaki, T. Shimosegawa, Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern, Journal of Viral Hepatitis, 2011, 18, 3
  4. 4
    Seong Ran Jeon, Jae Young Jang, Soung Won Jeong, Seung Hoon Park, Sae Hwan Lee, Sang Gyune Kim, Young Koog Cheon, Young Seok Kim, Young Deok Cho, Jong Ho Moon, Hong Soo Kim, Joon Seong Lee, Boo Sung Kim, HBV DNA Loss within 24 Weeks Predicts Late Viral Breakthrough in Chronic Hepatitis B, The Korean Journal of Gastroenterology, 2011, 58, 1, 25

    CrossRef

  5. 5
    Shuang Wu, Kenichi Fukai, Fumio Imazeki, Makoto Arai, Tatsuo Kanda, Yutaka Yonemitsu, Osamu Yokosuka, Initial Virological Response and Viral Mutation with Adefovir Dipivoxil Added to Ongoing Lamivudine Therapy in Lamivudine-Resistant Chronic Hepatitis B, Digestive Diseases and Sciences, 2011, 56, 4, 1207

    CrossRef

  6. 6
    Lucila Cassino, Silvina Benetti, Fabian Fay, Hugo Tanno, Jorge Quarleri, Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations, BMC Infectious Diseases, 2011, 11, 1, 178

    CrossRef

  7. 7
    Erik De Clercq, Geoffrey Férir, Suzanne Kaptein, Johan Neyts, Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections, Viruses, 2010, 2, 6, 1279

    CrossRef

  8. You have free access to this content8
    Rong-Nan Chien, On-treatment monitoring of chronic hepatitis B virus infection: An Asian–Pacific perspective, Journal of Gastroenterology and Hepatology, 2010, 25, 5
  9. You have free access to this content9
    L. J. Liu, J. H. Wang, S. C. Du, J. H. Tian, R. F. Yang, L. Wei, rtE218G, a novel hepatitis B virus mutation with resistance to adefovir dipivoxil in patients with chronic hepatitis B, Journal of Viral Hepatitis, 2010, 17,
  10. 10
    Elisabete Arrese, Miren Basaras, Sonia Blanco, Pablo Ruiz, Ramon Cisterna, Monitoring of therapy in patients with chronic hepatitis B virus, European Journal of Gastroenterology & Hepatology, 2009, 1

    CrossRef

  11. 11
    Samad Amini-Bavil-Olyaee, Ulf Herbers, Seyed Reza Mohebbi, Farzaneh Sabahi, Mohammad Reza Zali, Tom Luedde, Christian Trautwein, Frank Tacke, Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome, Journal of Hepatology, 2009, 51, 4, 647

    CrossRef